Correlation Between Microsoft and Evoke Pharma
Can any of the company-specific risk be diversified away by investing in both Microsoft and Evoke Pharma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Microsoft and Evoke Pharma into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Microsoft and Evoke Pharma, you can compare the effects of market volatilities on Microsoft and Evoke Pharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Microsoft with a short position of Evoke Pharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of Microsoft and Evoke Pharma.
Diversification Opportunities for Microsoft and Evoke Pharma
0.12 | Correlation Coefficient |
Average diversification
The 3 months correlation between Microsoft and Evoke is 0.12. Overlapping area represents the amount of risk that can be diversified away by holding Microsoft and Evoke Pharma in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Evoke Pharma and Microsoft is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Microsoft are associated (or correlated) with Evoke Pharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Evoke Pharma has no effect on the direction of Microsoft i.e., Microsoft and Evoke Pharma go up and down completely randomly.
Pair Corralation between Microsoft and Evoke Pharma
Given the investment horizon of 90 days Microsoft is expected to generate 0.32 times more return on investment than Evoke Pharma. However, Microsoft is 3.08 times less risky than Evoke Pharma. It trades about -0.04 of its potential returns per unit of risk. Evoke Pharma is currently generating about -0.4 per unit of risk. If you would invest 42,574 in Microsoft on August 28, 2024 and sell it today you would lose (695.00) from holding Microsoft or give up 1.63% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Microsoft vs. Evoke Pharma
Performance |
| Timeline |
| Microsoft |
| Evoke Pharma |
Microsoft and Evoke Pharma Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Microsoft and Evoke Pharma
The main advantage of trading using opposite Microsoft and Evoke Pharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Microsoft position performs unexpectedly, Evoke Pharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Evoke Pharma will offset losses from the drop in Evoke Pharma's long position.| Microsoft vs. GigaCloud Technology Class | Microsoft vs. Arqit Quantum | Microsoft vs. Cemtrex | Microsoft vs. Paysafe |
| Evoke Pharma vs. Petros Pharmaceuticals | Evoke Pharma vs. Cumberland Pharmaceuticals | Evoke Pharma vs. Painreform | Evoke Pharma vs. Aquestive Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Financial Widgets module to easily integrated Macroaxis content with over 30 different plug-and-play financial widgets.
Other Complementary Tools
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
| ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
| Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios |